| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50116-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26479-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26574-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26541-50ul | |||
![Immunohistochemistry: Bcl-6 Antibody (6E3) [NBP3-26479] - Image of Bcl-6 Antibody (6E3) diluted at 1:33 and staining in paraffin-embedded human testis tissue performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a Goat anti-rabbit polymer IgG labeled by HRP and visualized using 0.73% DAB.](http://images.novusbio.com/fullsize/nbp3-26479_rabbit-bcl-6-mab-6e3-2722024827490.jpg "Immunohistochemistry: Bcl-6 Antibody (6E3) [NBP3-26479] - Image of Bcl-6 Antibody (6E3) diluted at 1:33 and staining in paraffin-embedded human testis tissue performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a Goat anti-rabbit polymer IgG labeled by HRP and visualized using 0.73% DAB.")
![Flow Cytometry: Bcl-6 Antibody (6E3) [NBP3-26479] - Overlay Peak curve showing Jurkat cells stained with Bcl-6 Antibody (6E3) (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% Triton X-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.](http://images.novusbio.com/fullsize/nbp3-26479_rabbit-bcl-6-mab-6e3-282202414312764.jpg)
![Immunohistochemistry: HIST1H3A [Formyl Lys122] Antibody (32C1) [NBP3-26574] - Image of HIST1H3A [Formyl Lys122] Antibody (32C1) diluted at 1:100 and staining in paraffin-embedded human breast cancer performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a Goat anti-rabbit polymer IgG labeled by HRP and visualized using 0.09% DAB.](http://images.novusbio.com/fullsize/nbp3-26574_rabbit-hist1h3a-formyl-lys-122-mab-32c1-262202414471535.jpg "Immunohistochemistry: HIST1H3A [Formyl Lys122] Antibody (32C1) [NBP3-26574] - Image of HIST1H3A [Formyl Lys122] Antibody (32C1) diluted at 1:100 and staining in paraffin-embedded human breast cancer performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a Goat anti-rabbit polymer IgG labeled by HRP and visualized using 0.09% DAB.")
![Immunohistochemistry: HIST1H3A [Formyl Lys122] Antibody (32C1) [NBP3-26574] - Image of HIST1H3A [Formyl Lys122] Antibody (32C1) diluted at 1:100 and staining in paraffin-embedded human breast cancer performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a Goat anti-rabbit polymer IgG labeled by HRP and visualized using 0.09% DAB.](http://images.novusbio.com/fullsize/nbp3-26574_rabbit-hist1h3a-formyl-lys-122-mab-32c1-26220241525332.jpg)
![Immunocytochemistry/Immunofluorescence: Gelsolin/GSN Antibody (16H9) [NBP3-26541] - Staining of HepG2 with Gelsolin/GSN Antibody (16H9) at 1:50, counter-stained with DAPI. The cells were fixed in 4% formaldehyde and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4C. The secondary antibody was Alexa Fluor 510-conjugated Goat Anti-Rabbit IgG (H+L).](http://images.novusbio.com/fullsize/nbp3-26541_rabbit-gelsolin-gsn-mab-16h9-28220241312229.jpg "Immunocytochemistry/Immunofluorescence: Gelsolin/GSN Antibody (16H9) [NBP3-26541] - Staining of HepG2 with Gelsolin/GSN Antibody (16H9) at 1:50, counter-stained with DAPI. The cells were fixed in 4% formaldehyde and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4C. The secondary antibody was Alexa Fluor 510-conjugated Goat Anti-Rabbit IgG (H+L).")
![Flow Cytometry: Gelsolin/GSN Antibody (16H9) [NBP3-26541] - Overlay Peak curve showing HepG2 cells stained with Gelsolin/GSN Antibody (16H9) (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% Triton X-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.](http://images.novusbio.com/fullsize/nbp3-26541_rabbit-gelsolin-gsn-mab-16h9-282202414183681.jpg)
![Western Blot: BID [p Ser78] Antibody [NB500-260] - Detection of Mouse Phospho-BID (S78) after Treatment with EPE. Whole cell lysate (50 and 80 ug for WB; 1 mg for IP, 20% of IP loaded) from NIH3T3 cells that were treated with etoposide (100 mcM; 3 hours) or mock treated. Antibody used at 1 ug/ml.](http://images.novusbio.com/fullsize/BID-[p-Ser78]-Antibody-Western-Blot-NB500-260-img0004.jpg "Western Blot: BID [p Ser78] Antibody [NB500-260] - Detection of Mouse Phospho-BID (S78) after Treatment with EPE. Whole cell lysate (50 and 80 ug for WB; 1 mg for IP, 20% of IP loaded) from NIH3T3 cells that were treated with etoposide (100 mcM; 3 hours) or mock treated. Antibody used at 1 ug/ml.")
![Western Blot: 53BP2 Antibody [NB100-2858] - Detection of Human ASPP2 on HeLa whole cell lysates using NB100-2858. ASPP2 was also immunoprecipitated by rabbit anti-ASPP2 antibody NB100-2859.](http://images.novusbio.com/fullsize/53BP2-Antibody-Western-Blot-NB100-2858-img0001.jpg "Western Blot: 53BP2 Antibody [NB100-2858] - Detection of Human ASPP2 on HeLa whole cell lysates using NB100-2858. ASPP2 was also immunoprecipitated by rabbit anti-ASPP2 antibody NB100-2859.")
![Western Blot: HIST1H3A [Dimethyl Lys36] Antibody (1488) [NBP2-43763] - Various whole cell extracts (30 ug) were separated by 15% SDS-PAGE, and the membrane was blotted with HIST1H3A antibody [GT1488] (NBP2-43763) diluted at 1:1000. The HRP-conjugated anti-mouse IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/nbp2-43763_mouse-monoclonal-hist1h3a-dimethyl-lys36-antibody-1488-9102024201462.jpg "Western Blot: HIST1H3A [Dimethyl Lys36] Antibody (1488) [NBP2-43763] - Various whole cell extracts (30 ug) were separated by 15% SDS-PAGE, and the membrane was blotted with HIST1H3A antibody [GT1488] (NBP2-43763) diluted at 1:1000. The HRP-conjugated anti-mouse IgG antibody was used to detect the primary antibody.")
![Western Blot: FKBP38 Antibody (7-2#) [NBP3-41692] - Sample: Recombinant FKBP38, Human.](http://images.novusbio.com/fullsize/nbp3-41692_mouse-fkbp38-mab-7-2-6122024212795.jpg "Western Blot: FKBP38 Antibody (7-2#) [NBP3-41692] - Sample: Recombinant FKBP38, Human.")
![Western Blot: RAIDD/CRADD Antibody (23#) [NBP3-42110] - Western Blot; Sample: Recombinant RAIDD/CRADD, Human](http://images.novusbio.com/fullsize/nbp3-42110_mouse-raidd-cradd-mab-23-61220242058826.jpg "Western Blot: RAIDD/CRADD Antibody (23#) [NBP3-42110] - Western Blot; Sample: Recombinant RAIDD/CRADD, Human")
![Immunohistochemistry-Paraffin: TGF-beta 3 Antibody (C15) [NBP3-41629] - DAB staining on IHC-P; Sample: Human Cerebrum Tissue; Primary Ab: 30ug/ml NBP3-41629; Second Ab: 2ug/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody](http://images.novusbio.com/fullsize/nbp3-41629_mouse-tgf-beta-3-mab-c15-612202421331632.jpg "Immunohistochemistry-Paraffin: TGF-beta 3 Antibody (C15) [NBP3-41629] - DAB staining on IHC-P; Sample: Human Cerebrum Tissue; Primary Ab: 30ug/ml NBP3-41629; Second Ab: 2ug/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody")
![Western Blot: TGF-beta 3 Antibody (C1) [NBP3-41487] - Sample: Recombinant TGF-beta 3, Human.](http://images.novusbio.com/fullsize/nbp3-41487_mouse-tgf-beta-3-mab-c1-612202421121380.jpg "Western Blot: TGF-beta 3 Antibody (C1) [NBP3-41487] - Sample: Recombinant TGF-beta 3, Human.")
![Western Blot: TGF-beta 3 Antibody (C1) [NBP3-41487] - Sample: Human MCF7 cell lysate; Primary Ab: 3ug/ml NBP3-41487; Second Ab: 0.2ug/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody](http://images.novusbio.com/fullsize/nbp3-41487_mouse-tgf-beta-3-mab-c1-612202421395396.jpg)
![Western Blot: AXUD1 Antibody - BSA Free [NBP3-47903] - HeLa cells were subjected to SDS PAGE followed by western blot with (AXUD1 antibody) at dilution of 1:500](http://images.novusbio.com/fullsize/nbp3-47903_rabbit-axud1-pab-bsa-free-28420251134783.jpg "Western Blot: AXUD1 Antibody - BSA Free [NBP3-47903] - HeLa cells were subjected to SDS PAGE followed by western blot with (AXUD1 antibody) at dilution of 1:500")